Featured Insights
August 6, 2026
Client Alert
Against a backdrop of public sentiment and statements pushing rapid adoption of peptides, FDA's PCAC recommends allowing use of six peptides despite the Agency's presentations against them.
August 6, 2026
Client Alert
The resolution highlights for healthcare companies and private equity sponsors the importance of robust pre- and post-acquisition compliance diligence.
August 5, 2026
Blog
The changes will reduce the scope and lessen the long-term compliance burden for firms, albeit with a short-term cost.